Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-6-12
pubmed:abstractText
The aim of this study was to investigate whether the pentobarbitone anesthetized cat is a suitable preparation in which to characterize renal tubular dopamine receptors. Intravenous infusion of dopamine (10-100 micrograms/kg/min) resulted in a dose-related increase in mean blood pressure (MBP), urine output, sodium excretion (UNaV), and fractional sodium excretion (FENa). This diuretic effect occurred despite little change in glomerular filtration rate, suggesting that it is a consequence of decreased tubular reabsorption. Dopamine (10-100 micrograms/kg/min, i.v.) also induced marked dose-related falls in renal vascular conductance; however, renal blood flow was not significantly reduced. The increases in MBP, urine output, UNaV, and FENa induced by dopamine (10-100 micrograms/kg/min, i.v.), were unaffected by pretreatment of cats with either the selective dopamine DA1 or DA2 receptor antagonists, SCH 23390 (30 micrograms/kg, i.v.), or domperidone (100 micrograms/kg, i.v.) respectively. In contrast, pretreatment of cats with the nonselective alpha-adrenoceptor antagonist, phentolamine (1 mg/kg, i.v.) prevented dopamine-induced increases in urine output and MBP. Infusion of the selective dopamine DA1 receptor agonist fenoldopam (0.01-10 micrograms/kg/min) into the left renal artery failed to increase left renal vascular conductance, or left kidney urine output, UNaV, or FENa. In conclusion, this study provides no evidence for the involvement of renal tubular dopamine receptors in dopamine-induced diuresis in anesthetized cats. Rather, the diuretic effect appears to be linked to stimulation of alpha-adrenoceptors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0160-2446
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
267-76
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1709232-2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, pubmed-meshheading:1709232-Anesthesia, pubmed-meshheading:1709232-Animals, pubmed-meshheading:1709232-Benzazepines, pubmed-meshheading:1709232-Cats, pubmed-meshheading:1709232-Diuresis, pubmed-meshheading:1709232-Domperidone, pubmed-meshheading:1709232-Dopamine, pubmed-meshheading:1709232-Dopamine Agents, pubmed-meshheading:1709232-Dopamine Antagonists, pubmed-meshheading:1709232-Drug Interactions, pubmed-meshheading:1709232-Female, pubmed-meshheading:1709232-Fenoldopam, pubmed-meshheading:1709232-Hemodynamics, pubmed-meshheading:1709232-Kidney, pubmed-meshheading:1709232-Kidney Tubules, pubmed-meshheading:1709232-Male, pubmed-meshheading:1709232-Phentolamine, pubmed-meshheading:1709232-Receptors, Dopamine
pubmed:year
1991
pubmed:articleTitle
Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
pubmed:affiliation
Department of Peripheral Pharmacology, Glaxo Group Research Limited, Ware, Hertfordshire, England.
pubmed:publicationType
Journal Article